Kimberly-Clark to Buy Tylenol Maker Kenvue. Why the Stock Market Hates the Deal.

Kimberly-Clark agreed to buy Kenvue in a cash-and-stock transaction that values the Tylenol maker at an enterprise value of about $48.7 billion, including debt. Under the terms of the deal, Kenvue …